467 related articles for article (PubMed ID: 16916624)
1. Antiplatelet activity of carnosol is mediated by the inhibition of TXA2 receptor and cytosolic calcium mobilization.
Lee JJ; Jin YR; Lim Y; Hong JT; Kim TJ; Chung JH; Yun YP
Vascul Pharmacol; 2006 Sep; 45(3):148-53. PubMed ID: 16916624
[TBL] [Abstract][Full Text] [Related]
2. An antithrombotic agent, NQ301, inhibits thromboxane A2 receptor and synthase activity in rabbit platelets.
Jin YR; Cho MR; Lee KS; Lee JJ; Lim Y; Han XH; Oh KW; Hong JT; Yoo HS; Yun YP
Basic Clin Pharmacol Toxicol; 2005 Sep; 97(3):162-7. PubMed ID: 16128910
[TBL] [Abstract][Full Text] [Related]
3. Antiplatelet activity of J78 (2-Chloro-3-[2'-bromo, 4'-fluoro-phenyl]-amino-8-hydroxy-1,4-naphthoquinone), an antithrombotic agent, is mediated by thromboxane (TX) A2 receptor blockade with TXA2 synthase inhibition and suppression of cytosolic Ca2+ mobilization.
Jin YR; Cho MR; Ryu CK; Chung JH; Yuk DY; Hong JT; Lee KS; Lee JJ; Lee MY; Lim Y; Yun YP
J Pharmacol Exp Ther; 2005 Jan; 312(1):214-9. PubMed ID: 15328379
[TBL] [Abstract][Full Text] [Related]
4. The protective effects of paclitaxel on platelet aggregation through the inhibition of thromboxane A2 synthase.
Lee JJ; Yu JY; Lee JH; Zhang WY; Kim TJ; Myung CS; Yun YP
Arch Pharm Res; 2010 Mar; 33(3):387-94. PubMed ID: 20361303
[TBL] [Abstract][Full Text] [Related]
5. Antiplatelet activity of carnosic acid, a phenolic diterpene from Rosmarinus officinalis.
Lee JJ; Jin YR; Lee JH; Yu JY; Han XH; Oh KW; Hong JT; Kim TJ; Yun YP
Planta Med; 2007 Feb; 73(2):121-7. PubMed ID: 17410649
[TBL] [Abstract][Full Text] [Related]
6. Antiplatelet activity of epigallocatechin gallate is mediated by the inhibition of PLCgamma2 phosphorylation, elevation of PGD2 production, and maintaining calcium-ATPase activity.
Jin YR; Im JH; Park ES; Cho MR; Han XH; Lee JJ; Lim Y; Kim TJ; Yun YP
J Cardiovasc Pharmacol; 2008 Jan; 51(1):45-54. PubMed ID: 18209568
[TBL] [Abstract][Full Text] [Related]
7. 2-(2-Br-phenyl)-8-methoxy-benzoxazinone (HPW-RX2), a direct thrombin inhibitor with a suppressive effect on thromboxane formation in platelets.
Wu CC; Wang TW; Wang WY; Hsieh PW; Wu YC
Eur J Pharmacol; 2005 Dec; 527(1-3):37-43. PubMed ID: 16313903
[TBL] [Abstract][Full Text] [Related]
8. Novel thienylacylhydrazone derivatives inhibit platelet aggregation through cyclic nucleotides modulation and thromboxane A2 synthesis inhibition.
Brito FC; Kummerle AE; Lugnier C; Fraga CA; Barreiro EJ; Miranda AL
Eur J Pharmacol; 2010 Jul; 638(1-3):5-12. PubMed ID: 20412790
[TBL] [Abstract][Full Text] [Related]
9. Antiplatelet effect of sanguinarine is correlated to calcium mobilization, thromboxane and cAMP production.
Jeng JH; Wu HL; Lin BR; Lan WH; Chang HH; Ho YS; Lee PH; Wang YJ; Wang JS; Chen YJ; Chang MC
Atherosclerosis; 2007 Apr; 191(2):250-8. PubMed ID: 16797553
[TBL] [Abstract][Full Text] [Related]
10. Antiplatelet activity of beta-carboline alkaloids from Perganum harmala: a possible mechanism through inhibiting PLCgamma2 phosphorylation.
Im JH; Jin YR; Lee JJ; Yu JY; Han XH; Im SH; Hong JT; Yoo HS; Pyo MY; Yun YP
Vascul Pharmacol; 2009; 50(5-6):147-52. PubMed ID: 19073282
[TBL] [Abstract][Full Text] [Related]
11. Antiplatelet activity of hesperetin, a bioflavonoid, is mainly mediated by inhibition of PLC-gamma2 phosphorylation and cyclooxygenase-1 activity.
Jin YR; Han XH; Zhang YH; Lee JJ; Lim Y; Chung JH; Yun YP
Atherosclerosis; 2007 Sep; 194(1):144-52. PubMed ID: 17092506
[TBL] [Abstract][Full Text] [Related]
12. Antiplatelet effect of NQ12: a possible mechanism through the arachidonic acid cascade.
Jin YR; Han XH; Lee JJ; Lim Y; Kim TJ; Yoo HS; Hong JT; Lee CK; Yun YP
J Pharmacol Sci; 2007 Oct; 105(2):193-200. PubMed ID: 17951980
[TBL] [Abstract][Full Text] [Related]
13. Alteration of release and role of adenosine diphosphate and thromboxane A2 during collagen-induced aggregation of platelets from cattle with Chediak-Higashi syndrome.
Honda N; Ohnishi K; Fujishiro T; Ikeda M; Ito K
Am J Vet Res; 2007 Dec; 68(12):1399-406. PubMed ID: 18052747
[TBL] [Abstract][Full Text] [Related]
14. Antiplatelet effect of green tea catechins: a possible mechanism through arachidonic acid pathway.
Son DJ; Cho MR; Jin YR; Kim SY; Park YH; Lee SH; Akiba S; Sato T; Yun YP
Prostaglandins Leukot Essent Fatty Acids; 2004 Jul; 71(1):25-31. PubMed ID: 15172681
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms of antiplatelet activity of PC-09, a newly synthesized pyridazinone derivative.
Cherng SC; Huang WH; Shiau CY; Lee AR; Chou TC
Eur J Pharmacol; 2006 Feb; 532(1-2):32-7. PubMed ID: 16457809
[TBL] [Abstract][Full Text] [Related]
16. Platelet antiaggregating activity of ginsenosides isolated from processed ginseng.
Lee JG; Lee YY; Kim SY; Pyo JS; Yun-Choi HS; Park JH
Pharmazie; 2009 Sep; 64(9):602-4. PubMed ID: 19827304
[TBL] [Abstract][Full Text] [Related]
17. Antiplatelet effect of phloroglucinol is related to inhibition of cyclooxygenase, reactive oxygen species, ERK/p38 signaling and thromboxane A2 production.
Chang MC; Chang HH; Chan CP; Chou HY; Chang BE; Yeung SY; Wang TM; Jeng JH
Toxicol Appl Pharmacol; 2012 Sep; 263(3):287-95. PubMed ID: 22789837
[TBL] [Abstract][Full Text] [Related]
18. Effects of higenamine and its 1-naphthyl analogs, YS-49 and YS-51, on platelet TXA2 synthesis and aggregation.
Pyo MK; Kim JM; Jin JL; Chang KC; Lee DH; Yun-Choi HS
Thromb Res; 2007; 120(1):81-6. PubMed ID: 17020781
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological characterization of 2NTX-99 [4-methoxy-N1-(4-trans-nitrooxycyclohexyl)-N3-(3-pyridinylmethyl)-1,3-benzenedicarboxamide], a potential antiatherothrombotic agent with antithromboxane and nitric oxide donor activity in platelet and vascular preparations.
Buccellati C; Sala A; Rossoni G; Capra V; Rovati GE; Di Gennaro A; Folco G; Colli S; Casagrande C
J Pharmacol Exp Ther; 2006 May; 317(2):830-7. PubMed ID: 16399881
[TBL] [Abstract][Full Text] [Related]
20. Anti-platelet activity of KR-32560, a novel sodium/hydrogen exchanger-1 inhibitor.
Lee KS; Jin YR; Lee JJ; Lim Y; Son DJ; Lee CK; Yi KY; Yoo SE; Shin HS; Yun YP
Pharmacol Res; 2006 Mar; 53(3):265-70. PubMed ID: 16420980
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
